DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Perbak Capital Partners LLP's Holding History (CIK: 0001968437)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 12,611 Value ($000) $208 Avg Close $16.88 Range $13.75 - $20.61

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	12,611	$208	$16.88	$13.75 - $20.61